NewBiologix ^None

NewBiologix is a technology innovation company based in Lausanne, Switzerland that is developing a DNA integration platform for the advanced engineering of human and mammalian cell lines. The platform is used to manufacture gene and cell therapies, specifically for producing advanced therapy medicinal products. The company has raised $50 million in funding and aims to overcome manufacturing obstacles related to developing recombinant adeno-associated virus vectors.